CBKX Pharma
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
27-08
abbreviated format · 27 days late
2025
29-08
abbreviated format · 29 days late
2024
31-12
Financial
Equity above €200,000equity €221,547 ▲18.5%
With a profit in every financial year since 2021, equity grows to €221,547.
28-08
abbreviated format · 28 days late
2023
31-12
Financial
Weakest financial yearnet €19,382 ▼59.1%
The net result drops to €19,382, the lowest from 2021 to 2025. It recovers the following year.
29-08
micro format · 29 days late
2022
31-12
Financial
Equity above €150,000equity €167,547 ▲39.5%
With a profit in every financial year since 2021, equity grows to €167,547.
26-08
micro format · 26 days late
2020
03-07
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank